Article
The impact on clinical success from the 23andMe cohort
2024-06-18
Abstract excerpt
90% of therapeutic programs that enter clinical trials ultimately fail. Human genetic variation provides a set of “natural experiments” that can inform successful strategies for therapeutic discovery. Previous work has estimated that drug targets with human genetics supported mechanisms have a 2-3x increased likelihood of succeeding in the clinic compared to those without. 23andMe, Inc. is a direct-to-consumer gen...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- dc269208-a19c-5082-9153-6565abb84427
- DOI
- 10.1101/2024.06.17.24309059
